Haemonetics Corporation (NYSE:HAE) Signals Continued Margin Expansion Amid Short-Term Momentum Divergence
![]() |
Operational cash generation and margin gains support a constructive valuation backdrop, even as near-term price momentum shows signs of peaking. The company’s capital structure and revenue trajectory create a mixed but actionable setup for traders watching momentum and risk metrics. |








